Guided Therapeutics, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 5/03/2016
Contact Info
  • 5835 Peachtree Corners East
  • Suite D
  • Norcross, GA 30092

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0000924515
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3845 - Electromedical equipment
Incorporated In: DE, USA
Year of Inc. 1992
Employees 21 a/o Dec 31, 2006
Company Officers/Contacts
Gene S. Cartwright CEO, CFO
James Clavijo CFO
Bill Wells Director, Corp. Comm.
Company Directors
Michael C. James Chairman
Gene S. Cartwright
John E. Immhoff
Jonathan M. Niloff
Linda Rosenstock
Company Notes
  • Formerly=SpectRx, Inc. until 5-2008
Service Providers
Accounting/Auditing Firm
66 South Pearl Street, Suite 401
Albany, 12207
United States

Legal Counsel
Jones Day
1420 Peachtree st.
Atlanta, GA, 30309
United States

Investor Relations Firm
IRTH Communications, LLC
520 Broadway
Suite 350
Santa Monica, CA, 90401
United States

GTHP Security Details
Share Structure
Market Value1 $95,430 a/o Oct 24, 2016
Authorized Shares 1,000,000,000 a/o Dec 31, 2015
Outstanding Shares 153,919,886 a/o Aug 11, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders of Record 203 a/o Mar 15, 2016
Short Selling Data
Short Interest 682,601 (1,954.17%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security